Evaxion A (EVAX) Other Operating Expenses (2023 - 2026)
Evaxion A's (EVAX) quarterly Other Operating Expenses came in at -$3.8 million in Q1 2026, up 1.27% YoY from -$3.8 million in Q1 2025, and up 5.75% on a QoQ basis from -$4.1 million in Q4 2025.
Evaxion A (EVAX) Other Operating Expenses (2023 - 2026) Analysis & Trends
Evaxion A (EVAX) has 4 years of Other Operating Expenses data on file, last reported at -$3.8 million in Q1 2026.
- Quarterly Other Operating Expenses rose 1.27% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.8 million (up 49.61% YoY) and the FY2025 annual result came in at -$9.2 million, up 37.32% from the prior year.
- Other Operating Expenses climbed to -$3.8 million in Q1 2026, from -$4.1 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $11.4 million in Q2 2023 to a low of -$4.1 million in Q4 2025.
- A 4-year average of -$445428.6 and a median of -$3.8 million in 2026 frame the typical range for Other Operating Expenses.
- The widest YoY moves for Other Operating Expenses: up 274.58% in 2025, down 0.7% in 2025.
- Tracing EVAX's Other Operating Expenses over 4 years: stood at $11.4 million in 2023, then tumbled by 135.44% to -$4.0 million in 2024, then slipped by 0.7% to -$4.1 million in 2025, then advanced by 5.75% to -$3.8 million in 2026.
- The last three Other Operating Expenses figures came in at -$3.8 million (Q1 2026), -$4.1 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Evaxion A | 27.61 Mn | 27.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2023 | 11.35 Mn |